September 4-5, in Moscow took place the World Health Organization Conference on preventing the restoration of malaria transmission.
In a discussion of current issues of malaria elimination in the European Region participated George Ignatiev, Deputy Director for Science Programs in SPbSRIVS.
The malaria situation in Russian Federation in not the topic for discussion by public, nevertheless, annually up to 100 people fall ill with this disease in our country, there are also lethal outcomes. Malaria comes to our country thought travelers, students and working migrants. Following the dates of Federal Service for Supervision of Consumer Rights Protection and Human Welfare in Russia in 2015 were registered importation of the disease from 25 countries, including India, Egypt, Goa, Korea, Cameroon, Nigeria, Angola, Ghana, Sudan, Tanzania, etc.
In 2015 in the world according to WHO nearly half of world population was at the risk to of malaria, that’s why WHO set the global goal for period 2016-2030 to decrease for at least 90% of the incidence of malaria by 2030 by universal access to the prevention, diagnosis and treatment. Currently the malaria vaccine is a test application, which lead to the conditions for a wider use of this vaccine in 2018.
SPbSRIVS implementing the project of construction of Latin American Institute of Biotechnology MECHNIKOV in Nicaragua, which activities will be focused also on combating against dangerous and rare viral diseases. Supported by Pan American Health Organization the company will produce immunobiological products for the needs of Latin America and the Caribbean.
Malaria is caused by Plasmodium parasites. The parasites are spread to people through the bites of infected female Anopheles mosquitoes, called “malaria vectors.” In a non-immune individual, symptoms usually appear 10–15 days after the infective mosquito bite. If not treated within 24 hours, P. falciparum disease can progress to severe illness, often leading to death.